Oxbow Advisors LLC Purchases 2,875 Shares of Centene Co. (NYSE:CNC)

Oxbow Advisors LLC lifted its holdings in Centene Co. (NYSE:CNC) by 4.6% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 64,817 shares of the company’s stock after buying an additional 2,875 shares during the quarter. Oxbow Advisors LLC’s holdings in Centene were worth $4,879,000 as of its most recent SEC filing.

Other large investors also recently bought and sold shares of the company. Park Place Capital Corp lifted its stake in shares of Centene by 1,190.0% in the third quarter. Park Place Capital Corp now owns 387 shares of the company’s stock worth $29,000 after buying an additional 357 shares in the last quarter. WR Wealth Planners LLC raised its stake in shares of Centene by 41.4% in the second quarter. WR Wealth Planners LLC now owns 468 shares of the company’s stock worth $31,000 after purchasing an additional 137 shares during the last quarter. Chris Bulman Inc purchased a new stake in shares of Centene during the second quarter valued at $33,000. Riverview Trust Co lifted its stake in Centene by 154.6% during the 2nd quarter. Riverview Trust Co now owns 527 shares of the company’s stock valued at $35,000 after acquiring an additional 320 shares during the period. Finally, Thurston Springer Miller Herd & Titak Inc. bought a new stake in shares of Centene in the second quarter worth approximately $36,000. 93.63% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on CNC shares. Deutsche Bank Aktiengesellschaft raised their target price on shares of Centene from $82.00 to $87.00 and gave the stock a “hold” rating in a report on Friday, August 2nd. Barclays lowered their target price on Centene from $97.00 to $91.00 and set an “overweight” rating on the stock in a report on Tuesday, October 29th. StockNews.com downgraded Centene from a “strong-buy” rating to a “buy” rating in a research note on Monday, October 28th. Stephens reiterated an “equal weight” rating and issued a $78.00 price objective on shares of Centene in a research note on Monday, August 5th. Finally, Truist Financial cut their target price on shares of Centene from $92.00 to $89.00 and set a “buy” rating for the company in a research report on Monday, July 15th. Seven research analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. According to data from MarketBeat.com, Centene currently has a consensus rating of “Moderate Buy” and an average target price of $83.92.

Centene Price Performance

Shares of NYSE CNC traded down $2.37 during midday trading on Friday, reaching $60.15. 6,328,533 shares of the stock traded hands, compared to its average volume of 3,938,904. The company’s 50 day moving average is $69.71 and its 200 day moving average is $71.58. Centene Co. has a one year low of $59.77 and a one year high of $81.42. The stock has a market capitalization of $30.37 billion, a PE ratio of 10.44, a P/E/G ratio of 0.88 and a beta of 0.49. The company has a debt-to-equity ratio of 0.64, a current ratio of 1.10 and a quick ratio of 1.10.

Insider Buying and Selling at Centene

In related news, CEO Sarah London acquired 4,117 shares of the stock in a transaction dated Friday, November 8th. The stock was acquired at an average cost of $60.80 per share, with a total value of $250,313.60. Following the purchase, the chief executive officer now directly owns 667,229 shares of the company’s stock, valued at approximately $40,567,523.20. This trade represents a 0.00 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. 0.33% of the stock is owned by company insiders.

Centene Company Profile

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.